Nitric oxide and the cerebral circulation

Stroke

Volumn 25, Issue 3, 1994, Pages 692-703

  Faraci, Frank M ^a   Brian, Johnny E ^b  

^a Departments of Microbiology and Internal Medicine   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Cytotoxicity; Endothelium derived relaxing factor; Microcirculation; Nitric oxide

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

AUTOREGULATION; BRAIN CIRCULATION; CYTOTOXICITY; ENDOTHELIUM; ENZYME INDUCTION; GLIA; HUMAN; HYPERCAPNIA; HYPOXIA; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

AMINO ACID OXIDOREDUCTASES; ANIMALS; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; ENDOTHELIUM, VASCULAR; HUMANS; NEUROGLIA; NEURONS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; VASODILATION;

EID: 0028118673     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/01.STR.25.3.692     Document Type: Article

References (242)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373-376.
2. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: Physiology, pathoPhysiology, and pharmacology. Pharmacol Rev. 1991;43:109-142.
3. Faraci FM. Regulation of the cerebral circulation by endothelium. Pharmacol Ther. 1992;56:1-22.
4. Myers PR, Minor RL, Guerre R, Bates JN, Harrison DG. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature. 1990;345:161-164.
5. Bredt DS, Snyder SH. Nitric oxide, a novel neuronal messenger. Neuron. 1992;8:3-11.
6. Forstermann U, Schmidt HHHW, Pollack JS, Sheng H, Mitchell JA, Warner TD, Nakane M, Murad F. Isoforms of nitric oxide synthase. Biochem Pharmacol 1991;42:1849-1857.
7. Dinerman JL, Lowenstein CJ, Snyder SH. Molecular mechanisms of nitric oxide regulation: potential relevance to cardiovascular disease. Ore Res. 1993;73:217-222.
8. Marietta MA. Nitric oxide synthase structure and mechanism. J Biol Chem. 1993;268:12231-12234.
9. Geller DA, Lowenstein CJ, Shapiro RA, Nussler AK, Di Silvio M, Wang SC, Nalcayama DK, Simmons RL, Snyder SH, Billiar TR. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Nad Acad Sci USA. 1993;90:3491-3495.
10. Sessa WC, Harrison JK, Luthin DR, Pollock JS, Lynch KR. Genomic analysis and expression patterns reveal distinct genes for endothelial and brain nitric oxide synthase. Hypertension. 1993;21:934-938.
11. Schmidt HHHW, Lohmann SM, Walter U. The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim Biophys Acta. 1993;1178:153-175.
12. Rogers NE, Ignarro LJ. Constitutive nitric oxide synthase from cerebellum is reversibly inhibited by nitric oxide formed from L-arginine. Biochem Biophys Res Commun. 1992;189:242-249.
13. Rengasamy A, Johns RA. Regulation of nitric oxide synthase by nitric oxide. Mol Pharmacol 1993;44:124-128.
14. 2+/calmodulindependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem J. 1992;281:627-630.
15. Klatt P, Schmidt K, Uray G, Mayer B. Multiple catalytic functions of brain nitric oxide synthase. J Biol Chcm. 1993;268:14781-14787.
16. Pou S, Pou WS, Bredt DS, Snyder SH, Rosen GM. Generation of superoxide by purified brain nitric oxide synthase. J Biol Chem. 1992;267:24173-24176.
17. Bredt DS, Hwang PM, Snyder SH. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature. 1990;347:768-770.
18. Nozaki K, Moskowitz MA, Maynard KI, Koketsu N, Dawson TM, Bredt DS, Snyder SH. Possible origins and distribution of immunoreactive nitric oxide synthase-containing nerve fibers in cerebral arteries. J Cereb Blood Flow Metab. 1993;13:70-79.
19. Marsden PA, Schappert KT, Chen HS, Flowers M, Sundell CL, Wilcox JN, Lamas S, Michel T. Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett 1992;307:287-293.
20. Marshall JJ, Wei EP, Kontos HA. Independent blockade of cerebral vasodilation from acetylcholine and nitric oxide. Am J Physiol 1988;255:H847-H854.
21. Yang ST, Mayhan WG, Faraci FM, Heistad DD. Endotheliumdependent responses of cerebral blood vessels during chronic hypertension. Hypertension. 1991;17:612-618.
22. Rosenblum WI. Endothelium-derived relaxing factor in brain blood vessels is not nitric oxide. Stroke. 1992;23:1527-1532.
23. Kontos HA. Nitric oxide and nitrosothiols in cerebrovascular and neuronal regulation. Stroke. 1993;24(suppl I):I-155-I-158.
24. Kukreja RC, Wei EP, Kontos HA, Bates JN. Nitric oxide and S-nitroso-L-cysteine as endothelium-derived relaxing factors from acetylcholine in cerebral vessels in cats. Stroke. 1993;24:2010-2015.
25. Waldman SA, Murad F. Cyclic GMP synthesis and function. Pharmacol Rev. 1987;39:163-196.
26. -G-monomethyl-L-arginine in canine basilar artery. Stroke. 1991;22:1399-1404.
27. Katusic ZS, Marshall JJ, Kontos HA, Vanhoutte PM. Similar responsiveness of smooth muscle of the canine basilar artery to EDRF and nitric oxide. Am J Physiol 1989;257:H1235-H1239.
28. Kim P, Schini VB, Sundt TM, Vanhoutte PM. Reduced production of cGMP underlies the loss of endothelium-dependent relaxations in the canine basilar artery after subarachnoid hemorrhage. Ore Res. 1992;70:248-256.
29. Watanabe M, Rosenblum WI, Nelson GH. In vivo effect of methylene blue on endothelium-dependent and endothelium-independent dilations of brain mkrovessels in mice. Ore Res. 1988;62:86-90.
30. Alonso MJ, Salaices M, Sanchez-Ferrer CF, Marin J. Predominant role of nitric oxide in the relaxation induced by acetylcholine in cat cerebral arteries. J Pharmacol Exp Ther. 1992;261:12-20.
31. Faraci FM. Role of nitric oxide in regulation of basilar artery tone in vivo. Am J Physiol 1990;259:H1216-H1221.
32. Faraci FM. Role of endothelium-derived relaxing factor in cerebral circulation: large arteries vs microcirculation. Am J Physiol 1991;261:H1038-H1042.
33. G-nitro-L-arginine and L-arginine on regional cerebral blood flow in the cat. J Physiol 1992;449:183-196.
34. Wei EP, Kukreja R, Kontos HA. Effects of inhibition of nitric oxide synthesis on cerebral vasodilation and endothelium-derived relaxing factor from acetylcholine. Stroke. 1992;23:1623-1629.
35. Faraci FM, Heistad DD. Endothelium-derived relaxing factor inhibits constrictor responses of large cerebral arteries to serotonin. J Cereb Blood Flow Metab. 1992;12:500-506.
36. Szabo C, Csaki C, Benyo Z, Reivich M, Kovach AGB. Role of L-arginine nitric oxide pathway in the changes in cerebrovascular reactivity following hemorrhagic hypotension and retransfusion. Circ Shock. 1992;37:307-316.
37. Bauknight GC, Faraci FM, Heistad DD. Endothelium-derived relaxing factor modulates noradrenergic constriction of cerebral arterioles in rabbits. Stroke. 1992;23:1522-1526.
38. Rosenblum WI, Nishimura H, Nelson GH. Endothelium dependent L-arg- and L-NMMA-sensitive mechanisms regulate tone of brain microvessels. Am J Physiol 1990;259:H1396-H1401.
39. Busga DW, Leffler CW, Wagerle LC. Mono-L-arginine-containing compounds dilate piglet pial arterioles via an endothelium-derived relaxing factor-like substance. Circ Res. 1990;67:1374-1380.
40. Onoue H, Kaito N, Tokudome S, Abe T, Tashibu K, Nagashima H, Nakamura N. Investigation of postmortem functional changes in human cerebral arteries. J Cereb Blood Flow Metab. 1993;13:346-349.
41. Katusic ZS. Endothelial L-arginine pathway and regional cerebral arterial reactivity to vasopressin. Am J Physiol. 1992;262;H1557-H1562.
42. Ayajiki K, Okamura T, Toda N. Involvement of nitric oxide in endothelium-dependent phasic relaxation caused by histamine in monkey cerebral arteries. Jpn J Physiol 1992;60:357-362.
43. Cosentino F, Sill JC, Katusic ZS. Endothelial L-arginine pathway and relaxations to vasopressin in canine basilar artery. Am J Physiol 1993;264:H413-H418.
44. 3-agonist is reduced by inhibitors of nitric oxide and prostacyclin synthesis. Br J Pharmacol. 1992;105:103-106.
45. Faraci FM, Heistad DD. Role of ATP-sensitive potassium channels in the basilar artery. Am J Physiol 1992;264:H8-H13.
46. Fischer-Nalrielski H, Schror K. Nitric oxide is the endotheliumderived relaxing factor in bovine pial arterioles. Stroke. 1990; 21(suppl IV):IV-46-rV-48.
47. Frynn NM, Buljubasic N, Bosnjak ZJ, Kampine JP. Isofiurane produces endothelium-independent relaxation in canine middle cerebral arteries. Anesthesiology. 1992;76:461-467.
48. 2alpha-induced endotheliumdependent relaxation in isolated monkey cerebral arteries. Am J Physiol 1991;260:H1538-H1543.
49. Kitazono T, Heistad DD, Faraci FM. Activation of endothelin B receptors produces dilatation of the basilar artery in vivo. Circulation. 1993;88(suppl I):I-170. Abstract
50. Ohta F, Kobayashi Y, Shinozuka K, Shimoura K, Hattori K, Moritake K. Effects of nitro-L-arginine on endotheliumdependent relaxation of canine cerebral arteries. Clin Exp Pharmacol Physiol 1993;20:413-419.
51. Oyama H, Suzuki Y, Satoh S, Kajita Y, Takayasu M, Shibuya M, Sugita K. Role of nitric oxide in the cerebral vasodilatory responses to vasopressin and oxytocin in dogs. J Cereb Blood Flow Metab. 1993;13:285-290.
52. Suzuki Y, Satoh S, Oyama H, Takayasu M, Shibuya M. Regional differences in the vasodilator response to vasopressin in canine cerebral arteries in vivo. Stroke. 1993;24:1049-1054.
53. Toda N, Ayajiki K, Okamura T. Cerebroarterial relaxations mediated by nitric oxide derived from endothelium and vasodilator nerve. J Vasc Res. 1993;30:61-67.
54. Parsons AA, Schilling L, Wahl M. Analysis of acetylcholineinduced relaxation of rabbit isolated middle cerebral artery: effects of inhibitors of nitric oxide synthesis, Na, K-ATPase, and ATP-sensitive K channels. J Cereb Blood Flow Metab. 1991;11:700-704.
55. Rand VE, Garland CJ. Endothelium-dependent relaxation to acetylcholine in the rabbit basilar artery: importance of membrane potential. Br J Pharmacol. 1992;106:143-150.
56. Kontos HA, Wei EP, Marshall JJ. In vivo bioassay of endothelium-derived relaxing factor. Am J Physiol 1988;255:H1259-H1262.
57. Rosenblum WI. Endothelial dependent relaxation demonstrated in vivo in cerebral arterioles. Stroke. 1986;17:494-497.
58. Kontos HA, Wei EP, Kukreja RC, Ellis EF, Hess ML. Differences in endothelium-dependent cerebral dilation by bradykinin and acetylcholine. Am J Physiol 1990;258:H1261-H1266.
59. Kontos HA, Wei EP, Povlishock JT, Kukreja RC, Hess ML. Inhibition by arachidonate of cerebral arteriolar dilation from acetylcholine. Am J Physiol 1989;256:H665-H671.
60. Busija DW, Chen J. Effect of trigeminal neurotransmitters on piglet pial arterioles. J Dev Physiol 1992;18:67-72.
61. Mayhan WG. Endothelium-dependent responses of cerebral arterioles to adenosine 5′-diphosphate. J Vase Res. 1992;29:353-358.
62. Parsons AA, Schilling L, Wahl M. Nitric oxide as a modulator of 5-hydroxytryptamine-induced responses in rat pial arterioles in situ. In: Olesen J, Saxena PR, eds. 5-Hydraxytryptamine Mechanisms in Primary Headaches. New York, NY: Raven Press Publishers; 1992:157-162.
63. Rosenblum WI, Shimizu T, Nelson GH. Endothelium-dependent effects of substance P and calcitonin gene-related peptide on mouse pial arterioles. Stroke. 1993;24:1043-1048.
64. Faraci FM, Breese KR, Heistad DD. Nitric oxide contributes to dilatation of cerebral arterioles during seizures. Am J Physiol 1993;265:H2209-H2212.
65. Koenig HM, Pelligrino DA, Albrecht RF. Halothane vasodilation and nitric oxide in rat pial vessels. J Ncurosurg Anesthesiol. 1993;5:264-271.
66. Mayhan WG, Simmons LK, Sharpe GM. Mechanism of impaired responses of cerebral arterioles during diabetes mellitus. Am J Physiol 1991;260:H319-H326.
67. Shimokawa H, Kim P, Vanhoutte PM. Endothelium-dependent relaxation to aggregating platelets in isolated basilar arteries of control and hypercholesterolemic pigs. Circ Res. 1988;63:604-612.
68. Murphy S, Rich G, Orgren KI, Moore SA, Faraci FM. An astrocyte-derived lipoxygenase product evokes endotheliumdependent relaxation of the basilar artery. J Neurosci Res. In press.
69. Edwards DH, Byrne JV, Griffith TM. The effect of chronic subarachnoid hemorrhage on basal endothelium-derived relaxing factor activity in intrathecal cerebral arteries. J Neurosurg. 1992;76:830-837.
70. ++ antagonists in cerebral arteries. J Pharmacol Exp Ther. 1992;261:234-239.
71. Sugawa M, Koide T, Takato M. BY-1949 elicits vasodilatation via preferential elevation of cyclic GMP levels with the cerebral artery: possible involvement of endothelium-mediated mechanisms. Eur J Pharmacol 1992;215:57-62.
72. Gonzalez C, Estrada C. Nitric oxide mediates the neurogenic vasodilation of bovine cerebral arteries. J Cereb Blood Flow Metab. 1992;11:366-370.
73. o-monomethyl-L-arginine in canine basilar artery. In: Rubanyi GM, Vanhoutte PM, eds. Endothelium Derived Relaxing Factors. Basel, Switzerland: Karger Publishers; 1990:95-98.
74. Lee TJF, Sarwinski SJ. Nitric oxidergic neurogenic vasodilation in the porcine basilar artery. Blood Vessels. 1991;28:407-412.
75. Mombouli JV, Nephtali M, Vanhoutte PM. Effects of the converting enzyme inhibitor cilazaprilat on endothelium-dependent responses. Hypertension. 1991;18(suppl II):II-22-II-29.
76. Trezise DJ, Drew GM, Weston AH. Analysis of the depressant effect of the endothelium on contractions of rabbit isolated basilar artery to 5-hydroxytryptamine. Br J Pharmacol. 1992;106:587-592.
77. Brian JE, Kennedy RH. Modulation of cerebral arterial tone by endothelium-derived relaxing factor. Am J Physiol 1993;264:H1245-H1250.
78. G-nitro-L-arginine in isolated dog and monkey cerebral arteries. Stroke. 1993;24:1584-1589.
79. Prado R, Watson BD, Kuluz J, Dietrich WD. Endotheliumderived nitric oxide synthase inhibition: effects on cerebral blood flow, pial artery diameter, and vascular morphology in rats. Stroke. 1992;23:1118-1124.
80. Dirnagl U, Iindauer U, Villringer A. Nitric oxide synthase blockade enhances vasomotion in the cerebral microcirculation of anesthetized rats. Microvasc Res. 1993;45:318-323.
81. Kozniewska E, Oseka M, Stys T. Effects of endothelium-derived nitric oxide on cerebral circulation during normoria and hypoxia in the rat. J Cereb Blood Flow Metab. 1992;12:311-317.
82. G-nitro-L-arginine methyl ester on the cardiovascular system of the anesthetized rabbit and on the cardiovascular response to thyrotropin-releasing hormone. Br J Pharmacol. 1993;109:1219-1225.
83. Macrae IM, Dawson DA, Norrie JD, McCultoch J. Inhibition of nitric oxide synthesis: effects on cerebral blood flow and glucose utilisation in the rat. J Cereb Blood Flow Metab. 1993;13:985-992.
84. Nishikawa T, Kirsch JR, Koehler RC, Bredt DS, Snyder SH, Traytsman RJ. Effect of nitric oxide synthase inhibition on cerebral blood flow and injury volume during focal ischemia in cats. Stroke. 1993;24:1717-1724.
85. Tanaka K, Gotoh F, Gomi S, Takashima S, Mihara B, Shirai T, Nogawa S, Nagata E. Inhibition of nitric oxide synthesis induces a significant reduction in local cerebral blood flow in the rat. Neurosci Lett. 1991;127:129-132.
86. Iadecola C, Zhang F, Xu X. Role of nitric oxide synthasecontaining vascular nerves in cerebrovasodilation elicited from cerebellum. Am J Physiol 1993;264:R738-R746.
87. Northington FJ, Matherne GP, Berne RM. Competitive inhibition of nitric oxide synthase prevents the cortical hyperemia associated with peripheral nerve stimulation. Proc Natl Acad Sci USA. 1992;89:6649-6652.
88. Pelligrino DA, Miletkh DJ, Albrecht RF. Diminished muscarinic receptor-mediated cerebral blood flow response in streptozotocintreated rats. Am J Physiol 1992;262:E447-E454.
89. Pelligrino DA Koenig HM, Albrecht RF. Nitric oxide synthesis and regional cerebral blood flow responses to hypercapnia and hypoxia in the rat. J Cereb Blood Flow Metab. 1993;13:80-87.
90. Wei HM, Weiss HR, Sinha AK, Chi OZ. Effects of nitric oxide synthase inhibition on regional cerebral blood flow and vascular resistance in conscious and isoflurane-anesthetized rats. Anesth Analg. 1993;77:880-885.
91. Toda N, Ayajiki K, Okamura T. Neural mechanism underlying basilar arterial constriction by intracisternal L-NNA in anesthetized dogs. Am J Physiol. 1993;265:H103-H107.
92. Nishimura H, Rosenblum WI, Nelson GH, Boynton S. Agents that modify EDRF formation alter antiplatelet properties of brain arteriolar endothelium in vivo. Am J Physiol. 1991;261:H15-H21.
93. Rosenblum WI, Nishimura H, Ellis EF, Nelson GH. The endothelium-dependent effects of thimerosal on mouse pial arterioles in vivo: evidence for control of microvascular events by EDRF as well as prostaglandins. J Cereb Blood Flow Metab. 1992;12:703-706.
94. Miranda FJ, Torregrosa G, Salom JB, Alabadi JA, Jover T, Barbera MD, Alborch E. Endothelial modulation of 5-hydroxytryptamineinduced contraction in goat cerebral arteries. Gen Pharmacol. 1993;24:649-653.
95. Durieu-Trautmann O, Federici C, Creminon C, FoignantChaverot N, Roux F, Claire M, Strosberg AD, Couraud PO. Nitric oxide and endothelin secretion by brain microvessel endothelial cells: regulation by cyclic nucleotides. J Cell Physiol. 1993;155:104-111.
96. Kilbourn RG, Belloni P. Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin. J Natl Cancer Inst 1990;82:772-776.
97. Ueno M, Lee TJF. Endotoxin decreases the contractile responses of the porcine basilar artery to vasoactive substances. J Cereb Blood Flow Metab. 1993;13:712-719.
98. Brian JE, Heistad DD, Faraci FM. Lipopolysaccharide-induced cerebral arteriolar dilatation. FASEB J. In press.
99. Mayhan WG. Impairment of endothelium-dependent dilatation of basilar artery during chronic hypertension. Am J Physiol. 1990;259:H1455-H1462.
100. 2 in responses of cerebral arterioles during chronic hypertension. Am J Physiol. 1992;262:H539-H543.
101. Mayhan WG, Faraci FM, Heistad DD. Impairment of endothelium-dependent responses of cerebral arterioles in chronic hypertension. Am J Physiol. 1987;253:H1435-H1440.
102. Mayhan WG, Faraci FM, Heistad DD. Responses of cerebral arterioles to adenosine 5′-diphosphate, serotonin, and the thromboxane analogue U-46619 during chronic hypertension. Hypertension. 1988;12:556-561.
103. Fujii K, Heistad DD, Faraci FM. Effect of diabetes mellitus on flow-mediated and endothelium-dependent dilatation of the basilar artery. Stroke, 1992;23:1494-1498.
104. Mayhan WG. Impairment of endothelium-dependent dilatation of cerebral arterioles during diabetes mellitus. Am J Physiol. 1989;256:H621-H625.
105. Mayhan WG. Impairment of endothelium-dependent dilatation of the basilar artery in diabetes mellitus. Brain Res. 1992;580:297-302.
106. Rossitch E, Alexander E, Black PM, Cooke JP. L-Arginine normalizes endothelial function in cerebral vessels from hypercholesterolemic rabbits. J Clin Invest. 1991;87:1295-1299.
107. Hatake K, Wakabayashi I, Kakishita E, Hishida S. Impairment of endothelium-dependent relaxation in human basilar artery after subarachnoid hemorrhage. Stroke. 1992;23:1111-1117.
108. Vollmer DG, Takayasu M, Dacey RG. An in vitro comparative study of conducting vessels and penetrating arterioles after experimental subarachnoid hemorrhage in the rabbit. J Neurosurg. 1992;77:113-119.
109. Hongo K, Kassell NF, Nakagomi T, Sasaki T. Subarachnoid hemorrhage inhibition of endothelium-derived relaxing factor in rabbit basilar artery. J Neurosurg. 1988;69:247-253.
110. Kanamura K, Waga S, Tochio H, Nagatani K. The effect of atherosclerosis on endothelium-dependent relaxation in the aorta and intracranial arteries of rabbits. J Neurosurg. 1989;70:793-798.
111. Kanamaru K, Weir BKA, Rndlay JM, Krueger CA, Cook DA Pharmacological studies on relaxation of spastic primate cerebral arteries in subarachnoid hemorrhage. J Neurosurg. 1989;71:909-915.
112. Katusic ZS, Milde JH, Cosentino F, Mitrovic BS. Subarachnoid hemorrhage and endothelial L-arginine pathway in small brain stem arteries. Stroke. 1993;24:392-399.
113. Kim P, Sundt TM, Vanhoutte PM. Alterations in endotheliumdependent responsiveness of the canine basilar artery after subarachnoid hemorrhage. J Neurosurg. 1988;69:239-246.
114. Kim P, Lorenz RR, Sundt TM, Vanhoutte PM. Release of endothelium-derived relaxing factor after subarachnoid hemorrhage. J Neurosurg. 1989;70:108-114.
115. Mayhan WG, Amundsen S, Farad FM, Heistad DD. Responses of cerebral arteries after ischemia and reperfusion in cats. Am J Physiol. 1988;255:H879-H884.
116. Nelson CW, Wei EP, Povlishock JT, Kontos HA, Moskowitz MA. Oxygen radicals in cerebral ischemia. Am J Physiol. 1992;263:H1356-H1362.
117. Mayhan WG, Faraci FM, Baumbach GL, Heistad DD. Effects of aging on responses of cerebral arterioles. Am J Physiol. 1990;258:H1138-H1143.
118. Hatake K, Kakishita E, Wakabayashi I, Sakiyama N, Hishida S. Effect of aging on endothelium-dependent vascular relaxation of isolated human basilar artery to thrombin and bradykinin. Stroke. 1990;21:1039-1043.
119. Macdonald RL, Weir BKA. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke. 1991;22:971-982.
120. Ohshima H, Oguchi S, Adachi H, Iida S, Suzuki H, Sugimura T, Esumi H. Purification of nitric oxide synthase from bovine brain: immunological characterization and tissue distribution. Biochem Biophys Res Commun. 1992;183:238-244.
121. Valtschanoff JG, Weinberg RJ, Kharazia VN, Schmidt HHHW, Nakane M, Rustioni A. Neurons in rat cerebral cortex that synthesize nitric oxide: NADPH diaphorase histochemistry, NOS immunocytochemistry, and colocalization with GABA Neurosci Lett. 1993;157:157-161.
122. Hope BT, Michael GJ, Knigge KM, Vincent SR. Neuronal NADPH diaphorase is a nitric oxide synthase. Proc Natl Acad Sci USA. 1991;88:2811-2814.
123. Springall DR, Riveros-Moreno V, Buttery L, Suburo A, Bishop AE, Merrett M, Moncada S, Polak JM. Immunological detection of nitric oxide synthase(s) in human tissues using heterologous antibodies suggesting different isoforms. Histochemistry. 1992;98:259-266.
124. Schmidt HHHW, Gagne GD, Nakane M, Pollock JS, Miller MF, Murad F. Mapping of neural nitric oxide synthase in the rat suggests frequent co-localization with NADPH diaphorase but not soluble guanylyl cyclase, and novel paraneural functions for nitrinergic signal transduction. J Histochem Cytochem. 1992;40:1439-1456.
125. Regidor J, Edvinsson L, Divac I. NOS neurones lie near branchings of cortical arteriolae. Neuroreport 1993;4:112-114.
126. DeFelipe J. A study of NADPH diaphorase-positive axonal plexuses in the human temporal cortex. Brain Res. 1993;615:342-346.
127. Estrada C, Mengual E, Gonzalez C. Local NADPH-diaphorase neurons innervate pial arteries and lie close or project to intracranial blood vessels: a possible role for nitric oxide in the regulation of cerebral blood flow. J Cereb Blood Flow Metab. 1993;13:978-984.
128. Iadecola C, Beitz AJ, Renno W, Xu X, Mayer B, Zhang F. Nitric oxide synthase-containing neural processes on large cerebral arteries and cerebral microvessels. Brain Res. 1993;606:148-155.
129. Tracey WR, Nakane M, Pollock JS, Forstermann U. Nitric oxide synthases in neuronal cells, macrophages and endothelium are NADPH diaphorases, but represent only a fraction of total cellular NADPH diaphorase activity. Biochem Biophys Res Commun, 1993;195:1035-1040.
130. Iadecola C, Pellignno DA, Moskowitz MA, Lassen NA. Nitric oxide synthase inhibition and cerebrovascular regulation. J Cereb Blood Flow Metab. In press.
131. Adachi T, Inanami O, Sato A. Nitric oxide (NO) is involved in increased cerebral cortical blood flow following stimulation of the nucleus basalis of Meynert in anesthetized rats. Neumsci Lett. 1992;139:201-204.
132. Raszkiewicz JL, Linville DG, Kerwin JF, Wagenaar F, Arneric SP. Nitric oxide synthase is critical in mediating basal forebrain regulation of cortical cerebral circulation. J Neurosci Res 1992;33:129-135.
133. Iadecola C. Nitric oxide participates in the cerebrovasodilation elicited from cerebellar fastigial nucleus. Am J Physiol. 1992;263:R1156-R1161.
134. Garthwaite J. Glutamate, nitric oxide and cell-cell signaling in the nervous system. Trends Neurosci. 1991;14:60-67.
135. Garthwaite J, Charles SL, Chess-Williams R. Endotheliumderived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature. 1988;336:385-388.
136. Garthwaite J, Southam E, Anderton M. A kainate receptor linked to NO synthesis from arginine. J Neurochem. 1989;53:1952-1954.
137. Ambrosini A, Racagni G. Glutamate receptor-induced cyclic GMP formation in primary cultures of mesencephalic neurons. Biochem Biophys Res Commun. 1993;193:1098-1103.
138. Marin P, Quignard J-F, Lafon-Cazal M, Bockaert J. Non-classical glutamate receptors, blocked by both NMDA and non-NMDA antagonists, stimulate nitric oxide production in neurons. Neuropharmacology. 1993;32:29-36.
139. Okada D. Two pathways of cyclic GMP production through glutamate receptor-mediated nitric oxide synthesis. J Neurochem. 1992;59:1203-1210.
140. Kiedrowski L, Costa E, Wroblewski JT. Glutamate receptor agonists stimulate nitric oxide synthase in primary cultures of cerebellar granule cells. J Neurochem 1992;58:335-341.
141. Kiedrowski L, Costa E, Wroblewski JT. In vitro interaction between cerebellar astrocytes and granule cells: a putative role for nitric oxide. Neurosci Lett. 1992;135:59-61.
142. Marin P, Lafon-Cazal M, Bockaert J. A nitric oxide synthase activity selectively stimulated by NMDA receptors depends on protein kinase C activation in mouse striatal neurons. Eur J Neurosci. 1992;4:425-432.
143. Wood PL. Pharmacology of the second messenger, cyclic gua0 nosine 3′, 5′ monophosphate, in the cerebellum. Pharmacol Rev. 1991;43:l-25.
144. Wood PL, Emmett MR, Rao TS, der J, Mick S, lyengar S. Inhibition of nitric oxide synthase blocks N-methyl-D-aspartate-, quisqualate-, kainate-, harmaline-, and pentylenetetrazole-dependent increases in cerebellar cyclic GMP in vivo. J Neurochem. 1990;55:346-348.
145. Wood PL, Ryan R, U M. Excitatory ammo acid signal transduction in the hippocampus: role of noradrenergic afferents and nitric oxide in cGMP increases in vivo. Life Sci. 1992;51:601-606.
146. Faraci FM, Breese K. Nitric oxide mediates vasodilatation in response to activation of W-methyl-D-aspartate receptors in brain. Circ Res. 1993;72:476-480.
147. Armstead WM, Mirro R, Zuckerman S, Busija DW, Leffler CW. The influence of opioids on local cerebral glucose utilization in the newborn pig. Brain Res. 1992;571:97-102.
148. Busija DW, Leffler CW. Dilator effects of amino acid neurotransmitters on piglet pial arterioles. Am J Physiol. 1989;257:H1200-H1203.
149. Busija DW, Wei M. Altered cerebrovascular responsiveness to N-methyl-D-aspartate after asphyxia in piglets. Am J Physiol. 1993;265:H389-H394.
150. Faraci FM, Breese KR. Dilatation of cerebral arterioles in response to N-methyl-D-aspartate: role of CGRP and acetylcholine. Brain Res. In press.
151. Northington FJ, Traystman RJ. Local infusion of N-methyl-D-aspartate (NMDA) produces increases in cerebral blood flow (CBF) that can be blocked by the nitric oxide (NO) synthase antagonist N-nitro-L-arginine methyl ester (L-NAME). Ped Res. 1993;33:227A. Abstract.
152. Goadsby PJ, Kaube H, Hoskin KL. Nitric oxide synthesis couples cerebral blood flow and metabolism. Brain Res. 1992;595:167-170.
153. Dirnagl U, Lindaucr U, Villringer A. Role of nitric oxide in the coupling of cerebral blood flow to neuronal activation in rats. Neurosci Lett. 1993;149:43-46.
154. Duckrow RB. A brief hypoperfusion precedes spreading depression if nitric oxide synthesis is inhibited. Brain Res. 1993;618:190-195.
155. Hu J, El-Fakahany EE. Role of intercellular and intracellular communication by nitric oxide in coupling of muscarinic receptors to activation of guanylate cyclase in neuronal cells. J Neurochem. 1993;61:578-585.
156. Chaki S, Inagami T. New signaling mechanism of angiotensin II in neuroblastoma neuro-2A cells, activation of soluble guanylyl cyclase via nitric oxide synthesis. Mol Pharmacol. 1993;43:603-608.
157. Zarahn ED, Ye X, Ades AM, Reagan LP, Fluharty SJ. Angiotensininduced cyclic GMP production is mediated by multiple receptor subtypes and nitric oxide in N1E-115 neuroblastoma cells. J Neurochem. 1992;58:1960-1963.
158. 3) receptors. Eur J Biochem. 1990;189:547-552.
159. Forstermann U, Gorsky LD, Pollock JS, Ishii K, Schmidt HHHW, Heller M, Murad F. Hormone-induced biosynthesis of endothelium-derived relaxing factor/nitric oxide-like material in N1E-115 neuroblastoma cells requires calcium and calmodulin. Mol Pharmacol 1990;38:7-13.
160. 2+ ionophore raise cyclic GMP levels in a neuronal cell line via formation of nitric oxide. Br J Pharmacol. 1990;101:722-726.
161. Galea E, Feinstein DL, Reis DJ. Induction of calciumindependent nitric oxide synthase activity in primary rat glial cultures. Proc Natl Acad Sci USA. 1992;89:10945-10949.
162. Simmons ML, Murphy S. Induction of nitric oxide synthase in glial cells. J Neurochem. 1992;59:897-905.
163. Ceccatelli S, Lundberg JM, Fahrenkrug J, Bredt DS, Snyder SH, Hokflet T. Evidence for involvement of nitric oxide in the regulation of hypothalamic portal blood flow. Neuwscience. 1992;51:769-772.
164. Poeggel G, Muller M, Seidel I, Rechardt L, Bernstein H-G. Histochemistry of guanylate cyclase, phosphodiesterase, and NADPH-diaphorase (nitric oxide synthase) in rat brain vasculature. J Cardiovasc Pharmacol. 1992;20(suppl 12):S76-S79.
165. Suzuki N, Fukuuchi Y, Koto A, Naganuma Y, Isozumi K, Matsuoka S, Gotoh J, Shimizu T. Cerebrovascular NADPH diaphorase-containing nerve fibers in the rat. Neurosci Lett. 1993;151:1-3.
166. Toda N, Ayajiki K, Yoshida K, Kimura H, Okamura T. Impairment by damage for the pterygopalatine ganglion of nitroxidergic vasodilator nerve function in canine cerebral and retinal arteries. Ore Res. 1993;72:206-213.
167. Tomimoto H, Akiguchi I, Wakita H, Nakamura S, Kimura J. Distribution of NADPH-diaphorase in the cerebral blood vessels of rats: a histochemical study. Neurosci Lett. 1993;156:105-108.
168. Yamamoto R, Bredt DS, Snyder SH, Stone RA. The localization of nitric oxide synthase in the rat eye and related cranial ganglia. Neuwscience. 1993;54:189-200.
169. Morris R, Southam E, Gittins SR, Garthwaite J. NADPH-diaphorase staining in autonomic and somatic cranial ganglia of the rat. Neuroreport. 1993;4:62-64.
170. Chen F-Y, Lee TJ-F. Role of nitric oxide in neurogenic vasodilation of porcine cerebral artery. J Pharmacol Exp Ther. 1993;265:339-345.
171. Toda N, Okamura T. Mechanism underlying the response to vasodilator nerve stimulation in isolated dog and monkey cerebral arteries. Am J Physiol 1990;259:H1511-1517.
172. Toda N, Okamura T. Regulation of nitroxidergic nerve of arterial tone. News Physiol Sci. 1992;7:148-152.
173. Morita-Tsuzuki Y, Hardebo JE, Bouskela E. Inhibition of nitric oxide synthase attenuates the cerebral blood flow response to stimulation of postganglionic parasympathetic nerves in the rat. J Cereb Blood Flow Metab. 1993;13:993-997.
174. Aoki E, Semba R, Mikoshiba K, Kashiwamata S. Predominant localization in glial cells of free L-arginine: immunocytochemical evidence. Brain Res. 1991;547:190-192.
175. Murphy S, Simmons ML, Agullo L, Garcia A, Feinstein DL, Galea E, Reis DJ, Minc-Golomb D, Schwartz JP. Synthesis of nitric oxide in CNS glial cells. Trends Neuwsci. 1993;16:323-328.
176. Agullo L, Garcia A. Characterization of noradrenalinestimulated cyclic GMP formation in brain astrocytes in culture. BiochemJ. 1992;288:619-624.
177. Agullo L, Garcia A. Different receptors mediate stimulation of nitric oxide-dependent cyclic GMP formation in neurons and astrocytes in culture. Biochem Biophys Res Commun. 1992;182:1362-1368.
178. Murphy S, Minor RL, Welk G, Harrison DG. Evidence for an astrocyte-derived vasorelaxing factor with properties similar to nitric oxide. J Neurochem. 1990;55:349-351.
179. Murphy S, Minor RL, Welk G, Harrison DG. Central nervous system astroglial cells release nitrogen oxide(s) with vasorelaxant properties. J Cardiovasc Pharmacol. 1991;17(suppl 3):S265-S268.
180. Minc-Golomb D, Schwartz JP. Transcription of the brain nitric oxide synthase gene in neural cell cultures. Soc Neurosci Abstracts. 1992;18:1004. Abstract.
181. Murphy S, Kardos S, Moore SA, Orgren KI, Faraci FM. Astrocyte modulation of cerebral vessel function via eicosanoids and nitrosyl factors. Soc Neurosci Abstracts. 1992;18:784. Abstract.
182. Boje KM, Arora PK. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 1992;587:250-256.
183. Chao CC, Hu S, Molitor TW, Shaskan EG, Peterson PK. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol 1992;149:2736-2741.
184. Corradin SB, Mauel J, Donini SD, Quattrocchi E, RicciardiCastagnoli P. Inducible nitric oxide synthase activity of cloned murine microglial cells. Glia. 1993;7:255-262.
185. Demerle-Pallardy C, Lonchampt MO, Chabrier PE, Braquet P. Nitric oxide synthase induction in glial cells: effect on neuronal survival. Life Sci. 1993;52:1883-1890.
186. ++-calmodulin-independent NO-synthase. Biochem Biophys Res Commun. 1993;191:327-334.
187. Mollace V, Nistico G. E. coli lipopolysaccharide enhances the release of a NO-like factor from astrocytoma cells in culture. Prog Neuroendocrinimmunol. 1992;5:102-107.
188. Simmons ML, Murphy S. Cytokines regulate L-arginine-dependent cyclic GMP production in rat glial cells. Eur J Ncurosci. 1993;5:825-831.
189. Lee SC, Dickson DW, Liu W, Brosnan CF. Induction of nitric oxide synthase activity in human astrocytes by interleukin-l/3and interferon-gamma. J Neuroimmunol. 1993;46:19-24.
190. Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol. 1993;151:2132-2141.
191. Colasanti M, Mollace V, Cundari E, Massoud R, Nistico G, Lauro GM. The generation of nitric oxide participates in IFN-induced MHC class II antigen expression by cultured astrocytoma cells. Int J Immunopharmacol. 1993;15:763-771.
192. Galea E, Reis DJ, Feinstein DL. Cloning and expression of rat astroglial inducible nitric oxide synthase. Soc Neurosci Abstracts. 1993;19:1121. Abstract.
193. Mollace V, Colasanti M, Persichini T, Bagetta G, Lauro GM, Nistico G. HIV gpl20 glycoprotein stimulates the inducible isoform of NO synthase in human cultured astrocytoma cells. Biochem Biophys Res Commun. 1993;194:439-445.
194. Feinstein DL, Galea E, Reis DJ. Norepinephrine suppresses inducible nitric oxide synthase activity in rat astroglial cultures. J Neurochem. 1993;60:1945-1948.
195. Wallace MN, Fredens K. Activated astrocytes of the mouse hippocampus contain high levels of NADPH-diaphorase. Neuroreport. 1992;3:953-956.
196. Endoh M, Maiese K, Pulsinelli WA, Wagner JA. Reactive astrocytes express NADPH diaphorase in vivo after transient ischemia. Neurosci Lett. 1993;154:125-128.
197. Koprowski H, Zheng YM, Heber-Katz E, Fraser N, Rorke L, Fu ZF, Hanlon C, Dietzschold B. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc Natl Acad Sci USA. 1993;90:3024-3027.
198. Buchanan JE, Phillis JW. The role of nitric oxide in the regulation of cerebral blood flow. Brain Res. 1993;610:248-255.
199. ladecola C. Does nitric oxide mediate the increases in cerebral blood flow elicited by hypercapnia? Proc Natl Acad Sci USA. 1992;89:3913-3916.
200. ladecola C, Xu X. Nitro-L-arginine attenuates hypercapnic cerebrovasodilation without affecting cerebral metabolism. Am J Physiol. In press.
201. ladecola C, Zhang F. Nitric oxide-dependent and independent components of cerebrovasodilation elicited by hypercapnia. Am J Physiol. In press.
202. G-nitro-L-arginine on cerebral blood flow response to changes in carbon dioxide tension. J Cereb Blood Flow Metab. 1992;12:947-953.
203. Niwa K, Lindauer U, Villringer A, Dirnagl U. Blockade of nitric oxide synthesis in rats strongly attenuates the CBF response to extracellular activation. J Cereb Blood Flow Metab. 1993;13:535-539.
204. Saito S, Wilson DA, Hanley DF, Traystman RJ. Nitric oxide modulates cerebral blood vessel tone and depresses cerebrovascular resistance changes to carbon dioxide in anesthetized dog. J Cereb Blood Flow Metab. 1993;13(suppl 1):S153. Abstract.
205. 2 responsiveness of the cerebral and spinal cord vessels of the cat. J Cereb Blood Flow Metab. 1994;14:49-58.
206. + channels. FASEB J. In press.
207. 2 and bicarbonate on pial vessels. Stroke. 1977;8:358-360.
208. Toda N, Hatano Y, Mori K. Mechanisms underlying response to hypercapnia and bicarbonate of isolated dog cerebral arteries.Am J Physiol. 1989;257:H141-H146.
209. Toda N, Ayajiki K, Enokibori M, Okamura T. Monkey cerebral arterial relaxation caused by hypercapnic acidosis and hypertonic bicarbonate. Am J Physiol. 1993;265:H929-H933.
210. Dacey RG, Duling BR. A study of rat intracerebral arterioles: methods, morphology, and reactivity. Am J Physiol. 1982;243:H598-H606.
211. BertalanfFy H, Kawase T, Toya S. In vivo effect of visible light on feline cortical microcirculation. Acta Neurochir (Wein). 1993;121:174-180.
212. Pelligrino DA, Koenig HM, Sharp A. The effect of nitric oxide synthase (NOS) inhibition on pial arteriolar diameter changes during graded hypoxia in the rat. FASEB J. 1993;7:A529. Abstract.
213. Wang Q, Paulson OB, Lassen NA. Is autoregulation of cerebral blood flow in rats influenced by nitro-L-arginine, a blocker of the synthesis of nitric oxide? Acta Physiol Scand. 1992;145:297-298.
214. Tanaka K, Fukuuchi Y, Gomi S, Mihara B, Shirai T, Nogawa S, Nozaki H, Nagata E. Inhibition of nitric oxide synthesis impairs autoregulation of local cerebral blood flow in the rat. Neuroreport. 1993;4:267-270.
215. Malinski T, Bailey F, Zhang ZG, Chopp M. Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion. J Cereb Blood Flow Metab. 1993;13:355-358.
216. Sato S, Tominage T, Ohnishi T, Tsuyoshi Ohnishi S. EPR spintrapping study of nitric oxide formation during bilateral carotid occlusion in the rat. Biochim Biophys Acta. 1993;1181:195-197.
217. Tominaga T, Sato S, Ohnishi T, Tsuyoshi Ohnishi S. Potentiation of nitric oxide formation following bilateral carotid occlusion and focal cerebral ischemia in the rat: in vivo detection of the nitric oxide radical by electron paramagnetic resonance spin trapping. Brain Res. 1993;614:342-346.
218. Kader A, Frazzini VI, Solomon RA, Trifiletti RR. Nitric oxide production during focal cerebral ischemia in rats. Stroke, 1993;24:1709-1716.
219. Zhang ZG, Chopp M, Zaloga C, Pollock JS, Forstermann U. Cerebral endothelial nitric oxide synthase expression after focal cerebral ischemia in rats. Stroke. 1993;24:2016-2022.
220. Pelligrino DA. Saying NO to cerebral ischemia. J Neurosurg Anesthesiol. 1993;5:221-231.
221. Choi DW. Nitric oxide: foe or friend to the injured brain? Proc Natl Acad Sci U S A. 1993;90:9741-9743.
222. Manzoni O, Prezeau L, Marin P, Deshager S, Bockaert J, Fagni L. Nitric oxide-induced blockade of NMDA receptors. Neuron. 1992;8:653-662.
223. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA. 1990;87:1620-1624.
224. Dawson VL, Dawson TM, Bartley DA, Uhl GR, Snyder SH. Mechanisms of nitric oxide-mediated neurotccricity in primary brain cultures. J Neurosci 1993;13:2651-2661.
225. Reif DW. Delayed production of nitric oxide contributes to NMDA-mediated neuronal damage. Neuroreport. 1993;4:566-568.
226. Cazevielle C, Muller A, Meynier F, Bonne C. Superoxide and nitric oxide cooperation in hypoxia/reoxygenation-induced neuron injury. Free Radic Biol Med. 1993;14:389-395.
227. Buisson A, Plotkine M, Boulu RG. The neuroprotective effect of a nitric oxide inhibitor in a rat model of focal cerebral ischaemia. Br J Pharmacol. 1992;106:766-767.
228. G-nitro-L-arginine mitigates ischemic brain edema and subsequent cerebral infarction in rats. Neurosci Lett. 1992;147:159-162.
229. Nowicki JP, Duval D, Poignet H, Scatton B. Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse. Eur J Pharmacol. 1991;204:339-340.
230. Buisson A, Margaill I, Callebert J, Plotkine M, Boulu RG. Mechanisms involved in the neuroprotective activity of a nitric oxide synthase inhibitor during focal cerebral ischemia. J Neurochem. 1993;61:690-696.
231. Ashwal S, Cole DJ, Osborne TN, Pearce WJ. Low dose L-NAME reduces infarct volume in the rat MCAO/reperfusion model. J Neurosurg Anesthesiol. 1993;5:241-249.
232. G-nitro-L-arginine in focal stroke in the 7-day old rat. Eur J Pharmacol. 1992;218:197-198.
233. G-nitro-L-arginine enhances neuronal death following transient forebrain ischemia in gerbils. Neurosci Lett. 1992;146:139-142.
234. Yamamoto S, Golanov EV, Berger SB, Reis DJ. Inhibition of nitric oxide synthesis increases focal ischemic infarction in rat. J Cereb Blood Flow Metab. 1992;12:717-726.
235. Zhang F, Iadecola C. Nitroprusside improves blood flow and reduces brain damage after focal ischemia. Neuroreport. 1993;4:559-562.
236. Kuluz JW, Prado RJ, Dietrich WD, Schleien CL, Watson BD. The effect of nitric oxide synthase inhibition on infarct volume after reversible focal cerebral ischemia in conscious rats. Stroke. 1993;24:2023-2029.
237. Dawson DA, Kusumoto K, Graham DI, McCulloch J, Macrae IM. Inhibition of nitric oxide synthesis does not reduce infarct volume in a rat model of focal cerebral ischaemia. Neurosci Lett. 1992;142:151-154.
238. Moncada C, Lekieffre D, Arvin B, Meldrum B. Effect of NO synthase inhibition on NMDA- and ischaemia-induced hippocampal lesions. Neuroreport. 1992;3:530-532.
239. Morikawa E, Huang Z, Moskowitz MA. L-Arginine decreases infarct size caused by middle cerebral arterial occlusion in SHR. Am J Physiol. 1992;263:H1632-H1635.
240. Morikawa E, Rosenblatt S, Moskowitz MA. L-Arginine dilates rat pial arterioles by nitric oxide-dependent mechanisms and increases blood flow during focal cerebral ischaemia. Br J Pharmacol. 1992;107:905-907.
241. Lipton SA, Choi Y-B, Pan Z-H, Lei SZ, Chen H-SV, Sucher NJ, Loscalzo J, Singel DJ, Stamler JS. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 1993;364:626-632.
242. Liu T, McDonnell PC, Young PR, White RF, Siren AL, Hallenbeck JM, Barone FC, Feuerstein GZ. Interleukin-1/3 mRNA expression in ischemic rat cortex. Stroke. 1993;24:1746-1751.